MedTrace Logo

Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO

NCT03834051 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-03-18

Study results available
· View outcomes & findings →

Summary

The objective of this study is to assess the efficacy of FMTs via rectal administration for 1) symptom improvement in individuals with a formal diagnosis of dysbiosis due to active inflammatory bowel disease or irritable bowel syndrome; 2) clearance of antimicrobial resistant organism from the gastrointestinal tract.

Conditions

Interventions

BIOLOGICAL

Fecal Microbiota Transplantation

Fecal Microbiota Transplantation Rectal Administration Open Label

Sponsors & Collaborators

  • Vancouver Island Health Authority

    lead OTHER

Principal Investigators

  • Christine Lee · Vancouver Island Health Authority

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-06-30
Completion
2020-07-08

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834051 on ClinicalTrials.gov